Clik here to view.
HitGen Licenses Its Trk/ROS1 Inhibitor HG030 to Baiyunshan for Development...
CHENGDU, China HitGen Inc. (HitGen, 688222.SH) announces it has entered into a collaboration and licensing agreement with Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd (Baiyunshan,...
View ArticleClik here to view.
Prestige Biopharma and Teva Israel Announce License and Supply Agreement to...
SINGAPORE Prestige BioPharma Ltd. and Abic Marketing Ltd. (operates under the brand of Teva Israel, hereinafter “Teva Israel”), a subsidiary of Teva Pharmaceutical Industries Ltd. announced today...
View ArticleClik here to view.
武田肿瘤部在美国血液学会(ASH)第62届年会上展示其在血癌领域的领导地位
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited,...
View ArticleClik here to view.
武田薬品のオンコロジー部門が第62回米国血液学会（ASH）年次総会で血液がん治療におけるリーダーシップを示す
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
Taiho and Lung Therapeutics Enter Into an Exclusive License Agreement in...
TOKYO & AUSTIN, Texas Taiho Pharmaceutical Co., Ltd, (“Taiho”) and Lung Therapeutics, Inc. (“Lung Tx”) announced today an exclusive license agreement of LTI-01, a recombinant human single-chain...
View ArticleClik here to view.
Noxopharm Announces Pilot Study With Bristol Myers Squibb’s Product
SYDNEY Australian clinical-stage drug development company Noxopharm (ASX: NOX) is pleased to announce it has joined with Bristol Myers Squibb (NYSE: BMY) in an Australian pilot study investigating...
View ArticleClik here to view.
Daiichi Sankyo Creates New Business Unit to Unify Major Oncology Markets into...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that it will create a new Oncology Business Unit, effective April 1, 2021,...
View ArticleClik here to view.
Realize the Full Potential of the NextSeq 2000 with the Power of the P3...
SAN DIEGO Illumina, Inc. (NASDAQ: ILMN) is further extending the reach of the NextSeq™ 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The P3 flow cell...
View ArticleClik here to view.
KILL Realize the Full Potential of the NextSeq 2000 with the Power of the P3...
Illumina, Inc. requests that their press release NewsItemId: 20201112005379 “Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit” be removed. CONTACT Business Wire,...
View ArticleClik here to view.
P3試薬キットのパワーでNextSeq 2000システムの潜在能力をフルに活用
サンディエゴ （ビジネスワイヤ） — Illumina, Inc. (NASDAQコード: ILMN) は、高データ出力のP3フローセルの販売により、NextSeq™...
View ArticleClik here to view.
BeiGene Announces that RATIONALE 303 Trial of Tislelizumab in Non-Small Cell...
CAMBRIDGE, Mass. & BEIJING, China BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide,...
View ArticleClik here to view.
德昇济医药获得2亿美元融资，用于支持精准治疗药物的开发，以满足肿瘤和免疫领域的患者需求
上海 (美国商业资讯) –德昇济医药是一家专注于开发精准治疗药物并将其商业化的全球性生物技术公司。公司致力于改善现有标准治疗方案或开发替代方案，从而满足患者的需求。德昇济医药今天宣布获得2亿美元的A轮融资，该轮融资的投资者包括博裕资本、经纬中国、红杉中国、淡马锡和药明康德风险投资基金。本轮融资资金将用于支持德昇济医药开发治疗癌症和免疫疾病的产品管线组合。...
View ArticleClik here to view.
D3 Bio Launches with US$200 Million Investment to Develop Precision Medicines...
SHANGHAI D3 Bio, a global biotechnology company focused on developing and commercializing precision medicines to improve or replace existing standard-of-care treatments that do not fully meet...
View ArticleClik here to view.
PierianDx and Bench International Announce the Appointment of Mark McDonough...
ST. LOUIS & SAN DIEGO PierianDx, the leading clinical genomics informatics company, and Bench International, a leading global executive search firm, jointly announce the appointment of Mark...
View ArticleClik here to view.
MedTech Innovator Names X-ZELL as 2020 Asia Pacific Final Competition Winner
LOS ANGELES & SINGAPORE MedTech Innovator, the largest accelerator of medical devices in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only...
View ArticleClik here to view.
PierianDxとベンチ・インターナショナルがマーク・マクドナーを新たな最高経営責任者（CEO）に任命したと発表
セントルイス & サンディエゴ （ビジネスワイヤ） —...
View ArticleClik here to view.
PierianDx和Bench International宣布任命Mark McDonough为新的首席执行官
圣路易斯和旧金山 (美国商业资讯)–领先的临床基因组学信息公司PierianDx和全球领先的猎头公司Bench International共同宣布任命Mark...
View ArticleClik here to view.
AUM Biosciences and Newsoara Biopharma Announce a 5-year Transformational...
SINGAPORE AUM Biosciences (AUM), a global, clinical stage healthcare company focused on discovering, acquiring and developing novel oncology therapeutics and Newsoara Biopharma announced today that...
View ArticleClik here to view.
Genetron Health Named One of the “50 Smartest Companies in China 2020” by MIT...
BEIJING Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests,...
View ArticleClik here to view.
術後がん患者でMasimo SpHb®による非侵襲的・連続的ヘモグロビン測定を伴う患者血液管理プログラムの影響を追究した研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Blood Transfusion誌に掲載された研究結果を発表しました。研究ではAzienda USL-IRCCS（イタリア、レッジョ・エミリア）のLucia Merolle博士と同僚らが、術後がん患者のケアに、非侵襲的・連続的ヘモグロビン測定技術Masimo...
View Article